Betterlife Pharma Inc
(BETRF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 01/31
(Values in U.S. thousands)
| 10-2025 | 07-2025 | 04-2025 | 01-2025 | 10-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6 | 16 | 13 | 6 | 14 |
| Receivables | 8 | 7 | 6 | 8 | 5 |
| TOTAL | $210 | $167 | $163 | $163 | $199 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $210 | $167 | $163 | $163 | $199 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 397 | 390 | 576 | 595 | 35 |
| Accounts payable and accrued liabilities | 3,781 | 3,492 | 3,328 | 4,333 | 3,970 |
| Other current liabilities | 396 | 436 | 467 | 505 | 295 |
| TOTAL | $4,583 | $4,357 | $4,408 | $5,469 | $4,299 |
| Non-Current Liabilities | |||||
| Long Term Debt | 69 | 39 | 36 | 36 | 69 |
| Other Non-Current Liabilities | 8 | 7 | -3 | 22 | 667 |
| TOTAL | $69 | $39 | $36 | $36 | $766 |
| Total Liabilities | $4,652 | $4,396 | $4,444 | $5,505 | $5,065 |
| Shareholders' Equity | |||||
| Common Shares | 59,054 | 59,641 | 57,309 | 58,046 | 58,448 |
| Retained earnings | -86,252 | -86,816 | -83,605 | -86,041 | -86,309 |
| Other shareholders' equity | 22,755 | 22,946 | 22,014 | 22,654 | 22,995 |
| TOTAL | $-4,442 | $-4,229 | $-4,281 | $-5,341 | $-4,866 |
| Total Liabilities And Equity | $210 | $167 | $163 | $163 | $199 |